Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CohortFRA:C7K -3.87%92 EBIT per Share is €0.87 as of Apr. 2026. GuruFocus rates FRA:C7K with a GF Score™ of 92/100 and a GF Value™ of €13.34 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 271 Aerospace & Defense companies, Cohort ranks better than 61.62% on this metric.
Cohort's EBIT per Share for the
six
months ended in Apr. 2026 was €0.66.
Its EBIT per Share for the trailing twelve months (TTM) ended in Apr. 2026 was €0.87.
During the past 12 months, the average EBIT per Share Growth Rate of Cohort was 16.10% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 25.70% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 32.00% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 25.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Cohort's EBIT per Share or its related term are showing as below:
FRA:C7K'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -47 Med: 12.5 Max: 126.8
Current: 25.7
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Cohort was 126.80% per year. The lowest was -47.00% per year. And the median was 12.50% per year.
FRA:C7K's 3-Year EBIT Growth Rate is ranked better than 61.62% of 271
companies
in the Aerospace & Defense industry
Industry Median: 15.9
vs FRA:C7K: 25.70
Cohort's EBIT for the
six
months ended in Apr. 2026 was €31.0 Mil.
Cohort (FRA:C7K) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Cohort EBIT per Share Related Terms
Cohort EBIT per Share Historical Data
* Premium members only.
The historical data trend for Cohort's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Apr. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.87
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cohort (FRA:C7K) has a EBIT per Share of €0.87 as of Apr. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Cohort and its competitors. According to the industry distribution chart, Cohort ranks #104 out of 271 companies in the Aerospace & Defense industry, placing it in the top 38.4%.
Is Cohort's EBIT per Share too high?
Cohort's current EBIT per Share is €0.87. Based on the distribution chart, Cohort ranks #104 out of 271 companies in the Aerospace & Defense industry, which is above the industry midpoint. Overall, Cohort has a GF Score™ of 92/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cohort's EBIT per Share compare to SPCX and GE?
According to the Aerospace & Defense industry distribution chart, Cohort ranks #104 out of 271 companies for EBIT per Share. This puts Cohort in the upper half of its industry. The industry median EBIT per Share is 15.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for an Aerospace & Defense company?
The median EBIT per Share among Aerospace & Defense companies is 15.90, based on 271 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Cohort and its competitors. For the Aerospace & Defense industry, the median EBIT per Share is 15.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cohort's current EBIT per Share is €0.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cohort stock overvalued right now?
Based on GuruFocus' analysis, Cohort (FRA:C7K) is currently considered Modestly Overvalued. The stock's GF Value™ is €13.34, compared to a current price of €14.90 — trading 11.7% above its estimated fair value. The current EBIT per Share is €0.87. Cohort's overall GF Score™ is 92/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Cohort (FRA:C7K), the current EBIT per Share is €0.87 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cohort (FRA:C7K) Overvalued in 2026?
Based on GuruFocus' analysis, Cohort stock appears to be overvalued.
The current stock price of €14.90 is trading 11.7% above its estimated GF Value™ of €13.34.
GuruFocus considers Cohort to be Modestly Overvalued.
Key valuation signals for FRA:C7K:
EBIT per Share: €0.87
GF Value™: €13.34 vs. price of €14.90 (11.7% above fair value)
No single metric tells the full story. See the FRA:C7K stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cohort PLC is the parent company of seven businesses that provide services and products for customers in the defence, security, and related sectors in the United Kingdom and international markets. Its businesses include Chess, EID, ELAC Sonar, EM Solutions, MASS, MCL and SEA. The company has operations in UK, Portugal, Australia and Canada.
92GF Score
Get the complete analysis for FRA:C7K
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:C7K has been successfully added to your 
